| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Humbert M, Goubard A, Mansfield C, Hermine O, Dubreuil P, AB8939 Study Group T. Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939 Blood. 134: 2075-2075. DOI: 10.1182/blood-2019-122540 |
0.141 |
|
| 2017 |
Hammam K, Saez-Ayala M, Rebuffet E, Gros L, Lopez S, Hajem B, Humbert M, Baudelet E, Audebert S, Betzi S, Lugari A, Combes S, Letard S, Casteran N, Mansfield C, et al. Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology. Nature Communications. 8: 1420. PMID 29127277 DOI: 10.1038/s41467-017-01582-5 |
0.133 |
|
| 2012 |
Thamm DH, Rose B, Kow K, Humbert M, Mansfield CD, Moussy A, Hermine O, Dubreuil P. Masitinib as a chemosensitizer of canine tumor cell lines: A proof of concept study Veterinary Journal. 191: 131-134. PMID 21333567 DOI: 10.1016/j.tvjl.2011.01.001 |
0.084 |
|
| 1994 |
Humbert M, Raposo G, Cosson P, Reggio H, Davoust J, Salamero J. The invariant chain induces compact forms of class II molecules localized in late endosomal compartments. European Journal of Immunology. 23: 3158-66. PMID 8258330 DOI: 10.1002/EJI.1830231218 |
0.084 |
|
| 2010 |
Humbert M, Castéran N, Letard S, Hanssens K, Iovanna J, Finetti P, Bertucci F, Bader T, Mansfield CD, Moussy A, Hermine O, Dubreuil P. Masitinib combined with standard gemcitabine chemotherapy: In vitro and in vivo studies in human pancreatic tumour cell lines and ectopic mouse model Plos One. 5. PMID 20209107 DOI: 10.1371/journal.pone.0009430 |
0.079 |
|
| 2004 |
Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, Johnston JA. DUB-3, A Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation Journal of Biological Chemistry. 279: 13993-14000. PMID 14699124 DOI: 10.1074/jbc.M311291200 |
0.074 |
|
| 1991 |
Davoust J, Humbert M, Jouans O, Raposo G, Reggio H, Salamero J. Subcellular localization and sorting of MHC class II molecules Biology of the Cell. 73: 21a-21a. DOI: 10.1016/0248-4900(91)90157-I |
0.073 |
|
| 2001 |
Woods D, Cherwinski H, Venetsanakos E, Bhat A, Gysin S, Humbert M, Bray PF, Saylor VL, McMahon M. Induction of β3-Integrin Gene Expression by Sustained Activation of the Ras-Regulated Raf–MEK–Extracellular Signal-Regulated Kinase Signaling Pathway Molecular and Cellular Biology. 21: 3192-3205. PMID 11287623 DOI: 10.1128/Mcb.21.9.3192-3205.2001 |
0.073 |
|
| 2005 |
Gautier G, Humbert M, Deauvieau F, Scuiller M, Hiscott J, Bates EE, Trinchieri G, Caux C, Garrone P. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells. The Journal of Experimental Medicine. 201: 1435-46. PMID 15851485 DOI: 10.1084/jem.20041964 |
0.07 |
|
| 2018 |
Spasojevic C, Marangoni E, Vacher S, Assayag F, Meseure D, Château-Joubert S, Humbert M, Karam M, Ricort JM, Auclair C, Regairaz M, Bièche I. PKD1 is a potential biomarker and therapeutic target in triple-negative breast cancer. Oncotarget. 9: 23208-23219. PMID 29796183 DOI: 10.18632/oncotarget.25292 |
0.065 |
|
| 1994 |
Humbert M, Bertolino P, Forquet F, Rabourdin-Combe C, Gerlier D, Davoust J, Salamero J. Major histocompatibility complex class II-restricted presentation of secreted and endoplasmic reticulum resident antigens requires the invariant chains and is sensitive to lysosomotropic agents. European Journal of Immunology. 23: 3167-72. PMID 8258331 DOI: 10.1002/EJI.1830231219 |
0.062 |
|
| 2019 |
Goubard A, Humbert M, Mansfield C, Hermine O, Dubreuil P, AB8939 Study Group T. AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, Is Active across the Range (M0-M7) of Acute Myeloid Leukemia Subtypes Blood. 134: 5154-5154. DOI: 10.1182/blood-2019-127021 |
0.057 |
|
| 1993 |
Lombard-Platet S, Bertolino P, Gimenez C, Humbert M, Gerlier D, Rabourdin-Combe C. Invariant chain expression similarly controls presentation of endogenously synthesized and exogenous antigens by MHC class II molecules. Cellular Immunology. 148: 60-70. PMID 8495491 DOI: 10.1006/CIMM.1993.1091 |
0.05 |
|
| 2006 |
Gabillot-Carré M, Lepelletier Y, Humbert M, de Sepuvelda P, Hamouda NB, Zappulla JP, Liblau R, Ribadeau-Dumas A, Machavoine F, Letard S, Baude C, Hermant A, Yang Y, Vargaftig J, Bodemer C, et al. Rapamycin inhibits growth and survival of D816V-mutated c-kit mast cells. Blood. 108: 1065-72. PMID 16597595 DOI: 10.1182/blood-2005-06-2433 |
0.049 |
|
| 2019 |
Goubard A, Humbert M, Mansfield C, Hermine O, Dubreuil P, AB8939 Study Group T. In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-Derived Xenograft Models of Acute Myeloid Leukemia Blood. 134: 5142-5142. DOI: 10.1182/blood-2019-127143 |
0.039 |
|
| 2001 |
Migone T, Humbert M, Rascle A, Sanden D, D'Andrea A, Johnston JA. The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal Blood. 98: 1935-1941. PMID 11535532 DOI: 10.1182/Blood.V98.6.1935 |
0.037 |
|
| 1997 |
Ulitzur N, Humbert M, Pfeffer SR. Mapmodulin: a possible modulator of the interaction of microtubule-associated proteins with microtubules. Proceedings of the National Academy of Sciences of the United States of America. 94: 5084-9. PMID 9144194 DOI: 10.1073/Pnas.94.10.5084 |
0.028 |
|
| 1990 |
Salamero J, Humbert M, Cosson P, Davoust J. Mouse B lymphocyte specific endocytosis and recycling of MHC class II molecules. The Embo Journal. 9: 3489-3496. DOI: 10.1002/j.1460-2075.1990.tb07557.x |
0.024 |
|
| 2009 |
Dubreuil P, Letard S, Ciufolini M, Gros L, Humbert M, Castéran N, Borge L, Hajem B, Lermet A, Sippl W, Voisset E, Arock M, Auclair C, Leventhal PS, Mansfield CD, et al. Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT Plos One. 4. PMID 19789626 DOI: 10.1371/Journal.Pone.0007258 |
0.017 |
|
| Hide low-probability matches. |